Therapeutic Asset Ratings
9,928 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
alx2004
Esophageal Squamous Cell Carcinoma
ALX Oncology Inc.
P1
CC
(43)
Amg 410
Metastatic Neoplasm
Amgen
P1
CC
(43)
Amg 553
Acute Myeloid Leukemia
Amgen
P1
CC
(43)
Amg 794
Non-Small Cell Lung Carcinoma
Amgen
P1
CC
(43)
Amivantamab-Vmjw
Glioblastoma
Institute of Cancer Research, United Kingdom
P1
CC
(43)
Amivantamab-Vmjw
Malignant Glioma
Institute of Cancer Research, United Kingdom
P1
CC
(43)
Amt-151
Carcinoma
Multitude Therapeutics Inc.
P1
CC
(43)
Amt-151
Endometrium Adenocarcinoma
Multitude Therapeutics Inc.
P1
CC
(43)
Amt-151
Endometrial Clear Cell Adenocarcinoma
Multitude Therapeutics Inc.
P1
CC
(43)
Amt-151
Endometrial Endometrioid Adenocarcinoma
Multitude Therapeutics Inc.
P1
CC
(43)
Amt-151
Endometrial Serous Adenocarcinoma
Multitude Therapeutics Inc.
P1
CC
(43)
Amt-151
Malignant Pleural Mesothelioma
Multitude Therapeutics Inc.
P1
CC
(43)
Amt-151
Ovarian Clear Cell Adenocarcinoma
Multitude Therapeutics Inc.
P1
CC
(43)
Amt-151
Ovarian Mucinous Adenocarcinoma
Multitude Therapeutics Inc.
P1
CC
(43)
amx0114
Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals Inc.
P1
CC
(43)
an0025
Lung Cancer
Rutgers, The State University of New Jersey
P1
CC
(43)
AN4005
Lymphoma
Adlai Nortye Biopharma Co., Ltd.
P1
CC
(43)
and019 po qd
Breast Cancer
Kind Pharmaceuticals LLC
P1
CC
(43)
Anlotinib Hydrochloride Capsules
Small Cell Lung Carcinoma
Jinming Yu
P1
CC
(43)
Anti-Cd123 Car Nk Cells
Acute Myeloid Leukemia
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
Anti-Cd123 Car Nk Cells
CD4+/CD56+ Hematodermic Neoplasm
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
Anti-Cd19-Car Cmv-Specific T-Lymphocytes
High Grade B-Cell Lymphoma
City of Hope Medical Center
P1
CC
(43)
Anti-Cd19-Car Cmv-Specific T-Lymphocytes
Non-Hodgkin Lymphoma
City of Hope Medical Center
P1
CC
(43)
Anti-Cd19 Car-Nk Cells
Primary Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Anti-Cd19 Il10/Il15 Car-Nk
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Showing 901 to 925 of 9,928 assets
Previous
Page 37 of 398
Next